LSX World Congress USA June 2022

Morrison Foerster is proud to sponsor the LSX World Congress USA, June 21 -22, 2022 in Boston, MA. During the two-day conference, the leading biotech, medtech, and healthtech executives, investors, and trusted advisors will convene for programming, partnering, and networking opportunities.

On June 21 from 10:15 a.m. to 10:45 a.m., MoFo partner and former chief counsel of the FDA, Stacy Amin, will host the keynote fireside chat at the Biotech CEO Forum, “Navigating regulation and compliance in 2022 and beyond,” with Stephen Hahn, CEO & Partner of Flagship Pioneering, CEO of Harbinger Health, and former US FDA Commissioner (2019-2021). This conversation offers an insiders’ perspective on regulatory and compliance issues as well as strategic business advice for companies seeking approvals from 2022 and beyond.

Also on June 21, MoFo partner Matt Karlyn will lead the Healthtech CEO Forum, which offers executives the chance to exchange ideas with and seek advice from peers in a private group setting. Discussion topics will include “Remaining competitive in HealthTech – protection and commercialization practices.”

For more information or to register, visit the LXS website.